Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Are your everyday habits damaging your liver? It’s not just alcohol – even sugar, painkillers, and sitting too much can take ...

Q. Monsoon often triggers a spike in gastrointestinal infections. What are the most common liver-related complications observed during the season and how can th ...

Follow-up reached a median 5.5 years overall. Adverse liver outcomes in question counted cirrhosis, decompensation, ...

Anyone who knows an elementary school student probably knows Captain Underpants—the principal-turned-superhero who isn’t so ...

A South Korean biotech’s GLP-1 candidate has reduced liver fat in patients with metabolic dysfunction-associated ...

This baby girl had a rare condition and needed a liver transplant in order to survive. Her dad became her donor — and saved ...

DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert ...

Viking Therapeutics is quickly emerging as one of the most promising biotech stocks in the small-cap Russell 2000 index. With Wall Street analysts projecting a potential upside of ...

Actress and Bigg Boss OTT 2 winner Sana Makbul recently opened up about her ongoing health struggles. After a tough battle with autoimmune hepatitis, the actress revealed that she's now been diagnosed ...

Learn how SGLT2 inhibitor dapagliflozin improves MASH outcomes, with potential clinical use beyond diabetes care.